Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Diabetes Care|June 18, 2011
Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patientsNick Giannoukakis, Brett Phillips, David Finegold, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cellsJennifer Machen, Jo Harnaha, Robert Lakomy, et al.Plos One|January 28, 2014
Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD miceValentina Di Caro, Brett Phillips, Carl Engman, et al.Immunologic Research|April 9, 2011
Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacityValentina Di Caro, Antonella D'Anneo, Brett Phillips, et al.Diabetes|December 29, 2005
Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cellsJo Harnaha, Jennifer Machen, Marietta Wright, et al.Genome Research|June 3, 2005
Footer: a quantitative comparative genomics method for efficient recognition of cis-regulatory elementsDavid L Corcoran, Eleanor Feingold, Jessica Dominick, et al.The Journal of Biological Chemistry|August 15, 2002
Immunosuppressive effects of glucosamineLinlin Ma, William A Rudert, Jo Harnaha, et al.Clinical Immunology (Orlando, Fla.)|August 8, 2002
Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infectionSusanne Beckebaum, Vito R Cicinnati, Grzegorz Dworacki, et al.Diabetes|March 5, 2008
A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetesBrett Phillips, Karen Nylander, Jo Harnaha, et al.Pageof 1